NCT01891305View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Interdigital Tinea Pedis

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Tinea Pedis
Interventions
DRUG

VT-1161

DRUG

placebo

Trial Locations (7)

23507

Pariser Dermatology Specialists, Norfolk

27612

Wake Research Associates, Raleigh

33027

FXM Research, Miramar

33136

Florida Academic Dermatology Center, Miami

35233

Univ Alabama at Birmingham, Birmingham

77845

J&S Studies, Inc., College Station

97210

Oregon Dermatology & Research Center, Portland

All Listed Sponsors
lead

Viamet

INDUSTRY

NCT01891305 - A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Interdigital Tinea Pedis | Biotech Hunter | Biotech Hunter